A day in the life of a G protein‐coupled receptor: the contribution to function of G protein‐coupled receptor dimerization
- 1 March 2008
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (S1) , S216-S229
- https://doi.org/10.1038/sj.bjp.0707490
Abstract
G protein-coupled receptors are one of the most actively studied families of proteins. However, despite the ubiquity of protein dimerization and oligomerization as a structural and functional motif in biology, until the last decade they were generally considered as monomeric, non-interacting polypeptides. For the metabotropic glutamate-like group of G protein-coupled receptors, it is now firmly established that they exist and function as dimers or, potentially, even within higher-order structures. Despite some evidence continuing to support the view that rhodopsin-like G protein-coupled receptors are predominantly monomers, many recent studies are consistent with the dimerization/oligomerization of such receptors. Key roles suggested for dimerization of G protein-coupled receptors include control of protein maturation and cell surface delivery and providing the correct framework for interactions with both hetero-trimeric G proteins and arrestins to allow signal generation and its termination. As G protein-coupled receptors are the most targeted group of proteins for the development of therapeutic small molecule medicines, recent indications that hetero-dimerization between co-expressed G protein-coupled receptors may be a common process offers the potential for the development of more selective and tissue restricted medicines. However, many of the key experiments have, so far, been limited to model cell systems. Priorities for the future include the generation of tools and reagents able to identify unequivocally potential G protein-coupled receptor hetero-dimers in native tissues and detailed analyses of the influence of hetero-dimerization on receptor function and pharmacology.Keywords
This publication has 138 references indexed in Scilit:
- D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatumProceedings of the National Academy of Sciences, 2007
- Dimerization of the lutropin receptor: Insights from computational modelingMolecular and Cellular Endocrinology, 2007
- BRET analysis of GPCR oligomerization: newer does not mean betterNature Methods, 2007
- Asymmetric conformational changes in a GPCR dimer controlled by G-proteinsThe EMBO Journal, 2006
- Transmembrane Segment Peptides Can Disrupt Cholecystokinin Receptor Oligomerization without affecting Receptor FunctionBiochemistry, 2006
- Do orphan G‐protein‐coupled receptors have ligand‐independent functions?EMBO Reports, 2006
- The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsProceedings of the National Academy of Sciences, 2006
- The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerizationThe EMBO Journal, 2006
- Secretin Receptor Oligomers Form Intracellularly during Maturation through Receptor Core DomainsBiochemistry, 2006
- μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisBritish Journal of Pharmacology, 2006